We are live on ! Find out more
Neuberger Berman Group

Neuberger Berman Group Portfolio holdings

AUM $131B
1-Year Est. Return 28.36%
This Fund
S&P 500
This Quarter Est. Return
+25.27%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$80.5B
AUM Growth
+$14.9B
Cap. Flow
-$1.65B
Cap. Flow %
-2.05%
Top 10 Hldgs %
14.87%
Holding
1,659
New
136
Increased
550
Reduced
732
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 25.81%
2 Financials 13.12%
3 Healthcare 12.53%
4 Consumer Discretionary 10%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLNX
1626
DELISTED
Mellanox Technologies, Ltd.
MLNX
-105,293
Closed -$12.8M
TGE
1627
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
-22,800
Closed -$375K
RTN
1628
DELISTED
Raytheon Company
RTN
-591,048
Closed -$77.5M
S
1629
DELISTED
Sprint Corporation
S
-1,163,982
Closed -$10M
EGLE
1630
DELISTED
Eagle Bulk Shipping Inc.
EGLE
-474,467
Closed -$6.14M
CY
1631
DELISTED
Cypress Semiconductor
CY
-1,799,063
Closed -$42M

Similar funds

Neuberger Berman Group's Q2 2020 Portfolio in Review

As of Q2 2020, Neuberger Berman Group held 1,659 positions worth $80.5B, up 23% from $65.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Neuberger Berman Group's Q2 2020 filing shows 136 new, 550 increased, 732 reduced and 126 closed positions. Its largest new stake was Biora Therapeutics, Inc. Common Stock: 26,164 shares worth $58.9M. The largest sale was Proofpoint, Inc., an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Neuberger Berman Group's largest Q2 2020 buy was Biora Therapeutics, Inc. Common Stock: 26,164 shares worth $58.9M.
  • Neuberger Berman Group added most to TJX Companies in Q2 2020, an estimated $163M increase.
  • Neuberger Berman Group's biggest Q2 2020 reduction was Proofpoint, Inc., cutting an estimated $121M.
  • Neuberger Berman Group fully exited Allergan plc in Q2 2020, selling an estimated $116M.
  • Neuberger Berman Group's ten largest holdings make up 15% of its $80.5B portfolio in Q2 2020.
  • Neuberger Berman Group opened 136 new positions and closed 126 in Q2 2020.
  • Neuberger Berman Group's portfolio value rose 23% quarter-over-quarter to $80.5B.

Based on Neuberger Berman Group's 13F filing for Q2 2020, filed 13 Aug 2020.